Market Overview:
The global blood serum market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for blood serum in the cell culture media, cell line saving, tissue culture, and diagnostic reagents applications. Additionally, rising awareness about the benefits of using blood serum is also contributing to the growth of this market. On the basis of type, bovine blood serum accounted for majority share of the global market in 2017. This can be attributed to its high purity and low cost as compared to other types of blood serums available in the market. However, equinebloodserum is projectedto register highest CAGR during forecast period owingto its properties such as anti-inflammatory and immunomodulatory effects which make it suitable for use inculture mediaandcell line saving applications.
Product Definition:
A clear, pale yellow fluid that is the watery portion of blood and lymph, in which the red and white corpuscles are suspended. It is used as a vaccine carrier and to dilute drugs for injection.
Bovine:
Bovine is the term used for cattle that are born, raised and processed in farms. The bovine population has been on a steady rise over the past few years due to technological advancements in dairy farming and increasing demand for milk products such as butter, yogurt, ice cream and cheese.
Equine:
Equine is the natural source of hemoprotein and it's used in Blood Serum for replacement therapy. Equine blood products are widely used as a substitute for human plasma in various therapeutic applications such as hemostasis and thrombosis. It helps to decrease the risk of complications associated with diseases such as myocardial infarction, stroke, renal failure, and hemorrhage among others by 50%.
Application Insights:
Based on the application, the global blood serum market is segmented into cell culture media, cell line saving, tissue culture and diagnostic reagents. The cell line saving segment held a major share in 2015 owing to its extensive usage in research and development of cancer therapies. Tissue culture is anticipated to be one of the fastest growing segments over the forecast period due to increasing demand for stem cells worldwide.
The use of blood serum as a medium for culturing cells has been known since 1920s when it was first used by Frederick Maitland Armstrong as an alternative medium for studying cellular growth. Moreover, it has been found that bovine blood serum contains proteins that are capable of stimulating bacterial growth which makes it an ideal substitute for bacterial cultivation during clinical trials involving human volunteers (phase I & II). This factor along with others such as high biobanking potential will drive product demand from diagnostic reagents segment over the forecast period.
Regional Analysis:
North America dominated the global blood serum market in 2017. The presence of a large number of pharmaceutical and biopharmaceutical companies, advanced healthcare infrastructure, high adoption rate for advanced technologies are some major factors responsible for its largest share. In addition, increasing R&D activities to develop novel products is also expected to drive the regional demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by various governments in developing countries such as China and India. These countries have a huge population base which can be used as source material for animal-based cell cultures; this factor will further boost revenue generation in APAC region during the forecast years. Moreover, growing awareness regarding blood donation & preservation programs will also support regional growth through 2030 time line).
Growth Factors:
- Increasing demand for blood serum products for research and development purposes.
- Rising prevalence of chronic diseases such as cancer, diabetes, and heart diseases which is expected to increase the demand for blood serum products.
- Growing awareness about the benefits of using blood serum products among consumers is anticipated to boost the growth of this market during the forecast period.
- Technological advancements in manufacturing processes are projected to fuel the growth of this market in near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Serum Market Research Report
By Type
Bovine, Equine, Porcine, Others
By Application
Cell Culture Media, Cell Line Saving, Tissue Culture, Diagnostic Reagents
By Companies
Thermo Fisher (Life-Tech), Sigma-Aldrich, Merck, Corning, Bioind, Gemini, Bovogen, Moregate Biotech, VWR, South Pacific Sera, Thermo Fisher (Life-Tech), Lanzhou Minhai, Zhejiang Tianhang, Jin Yuan Kang, Wuhan Sanli, Changchun Xinuo, Caoyuan Lvye, MRC, Lanzhou Roya
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Blood Serum Market Report Segments:
The global Blood Serum market is segmented on the basis of:
Types
Bovine, Equine, Porcine, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Culture Media, Cell Line Saving, Tissue Culture, Diagnostic Reagents
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher (Life-Tech)
- Sigma-Aldrich
- Merck
- Corning
- Bioind
- Gemini
- Bovogen
- Moregate Biotech
- VWR
- South Pacific Sera
- Thermo Fisher (Life-Tech)
- Lanzhou Minhai
- Zhejiang Tianhang
- Jin Yuan Kang
- Wuhan Sanli
- Changchun Xinuo
- Caoyuan Lvye
- MRC
- Lanzhou Roya
Highlights of The Blood Serum Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bovine
- Equine
- Porcine
- Others
- By Application:
- Cell Culture Media
- Cell Line Saving
- Tissue Culture
- Diagnostic Reagents
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Serum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood serum is a fluid that contains blood cells, proteins, and other substances. It is used to test the health of a person's blood vessels and to diagnose diseases.
Some of the major players in the blood serum market are Thermo Fisher (Life-Tech), Sigma-Aldrich, Merck, Corning, Bioind, Gemini, Bovogen, Moregate Biotech, VWR, South Pacific Sera, Thermo Fisher (Life-Tech), Lanzhou Minhai, Zhejiang Tianhang, Jin Yuan Kang, Wuhan Sanli, Changchun Xinuo, Caoyuan Lvye, MRC, Lanzhou Roya.
The blood serum market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Serum Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Serum Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Serum Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Serum Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Serum Market Size & Forecast, 2020-2028
4.5.1 Blood Serum Market Size and Y-o-Y Growth
4.5.2 Blood Serum Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bovine
5.2.2 Equine
5.2.3 Porcine
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cell Culture Media
6.2.2 Cell Line Saving
6.2.3 Tissue Culture
6.2.4 Diagnostic Reagents
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Serum Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Serum Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bovine
9.6.2 Equine
9.6.3 Porcine
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cell Culture Media
9.10.2 Cell Line Saving
9.10.3 Tissue Culture
9.10.4 Diagnostic Reagents
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bovine
10.6.2 Equine
10.6.3 Porcine
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cell Culture Media
10.10.2 Cell Line Saving
10.10.3 Tissue Culture
10.10.4 Diagnostic Reagents
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bovine
11.6.2 Equine
11.6.3 Porcine
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cell Culture Media
11.10.2 Cell Line Saving
11.10.3 Tissue Culture
11.10.4 Diagnostic Reagents
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bovine
12.6.2 Equine
12.6.3 Porcine
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cell Culture Media
12.10.2 Cell Line Saving
12.10.3 Tissue Culture
12.10.4 Diagnostic Reagents
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bovine
13.6.2 Equine
13.6.3 Porcine
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cell Culture Media
13.10.2 Cell Line Saving
13.10.3 Tissue Culture
13.10.4 Diagnostic Reagents
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Serum Market: Competitive Dashboard
14.2 Global Blood Serum Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher (Life-Tech)
14.3.2 Sigma-Aldrich
14.3.3 Merck
14.3.4 Corning
14.3.5 Bioind
14.3.6 Gemini
14.3.7 Bovogen
14.3.8 Moregate Biotech
14.3.9 VWR
14.3.10 South Pacific Sera
14.3.11 Thermo Fisher (Life-Tech)
14.3.12 Lanzhou Minhai
14.3.13 Zhejiang Tianhang
14.3.14 Jin Yuan Kang
14.3.15 Wuhan Sanli
14.3.16 Changchun Xinuo
14.3.17 Caoyuan Lvye
14.3.18 MRC
14.3.19 Lanzhou Roya
